Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 24ELI LILLY AND CO

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Approval Date : 2022-05-13

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Approval Date : 2022-05-13

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Approval Date : 2022-05-13

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Approval Date : 2022-05-13

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12.5MG/0.5ML (12.5MG/0.5ML)

Approval Date : 2022-05-13

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO (AUTOINJECTOR)

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 15MG/0.5ML (15MG/0.5ML)

Approval Date : 2022-05-13

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 2.5MG/0.5ML (2.5MG/0.5ML)

Approval Date : 2023-07-28

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 5MG/0.5ML (5MG/0.5ML)

Approval Date : 2023-07-28

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 7.5MG/0.5ML (7.5MG/0.5ML)

Approval Date : 2023-07-28

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

TIRZEPATIDE

Brand Name : MOUNJARO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 10MG/0.5ML (10MG/0.5ML)

Approval Date : 2023-07-28

Application Number : 215866

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank